Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M N Smith

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1996
Preclinical pharmacology of CB30900, a novel dipeptide inhibitor of thymidylate synthase, in miceM I Walton, W Gibson, G W Aherne, et al.
Annals of the Rheumatic Diseases|December 1, 1983
1 Alpha 2 alpha 3 alpha collagen is arthritogenicK Morgan, H B Evans, S A Firth, et al.
Archives of Environmental Health|November 1, 1988
Effect of metaproterenol sulfate on mild asthmatics' response to sulfur dioxide exposure and exerciseW S Linn, E L Avol, D A Shamoo, et al.
Toxicology and Industrial Health|December 1, 1989
Experimental exposures of young asthmatic volunteers to 0.3 ppm nitrogen dioxide and to ambient air pollutionE L Avol, W S Linn, R C Peng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1997
Cellular pharmacology and in vivo activity of a new anticancer agent, ZD9331: a water-soluble, nonpolyglutamatable, quinazoline-based inhibitor of thymidylate synthaseA L Jackman, R Kimbell, G W Aherne, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Substituted-2-desamino-2-methyl-quinazolinones. A series of novel antitumour agentsF T Boyle, Z S Matusiak, L R Hughes, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Gamma-linked dipeptide analogues of 2-desamino-2-methyl-N10-propargyl-5,8- dideazafolate as antitumour agentsA L Jackman, G M Bisset, D I Jodrell, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1996
Preclinical pharmacology of CB30900, a novel dipeptide inhibitor of thymidylate synthase, in miceM I Walton, W Gibson, G W Aherne, et al.
Annals of the Rheumatic Diseases|December 1, 1983
1 Alpha 2 alpha 3 alpha collagen is arthritogenicK Morgan, H B Evans, S A Firth, et al.
Archives of Environmental Health|November 1, 1988
Effect of metaproterenol sulfate on mild asthmatics' response to sulfur dioxide exposure and exerciseW S Linn, E L Avol, D A Shamoo, et al.
Toxicology and Industrial Health|December 1, 1989
Experimental exposures of young asthmatic volunteers to 0.3 ppm nitrogen dioxide and to ambient air pollutionE L Avol, W S Linn, R C Peng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1997
Cellular pharmacology and in vivo activity of a new anticancer agent, ZD9331: a water-soluble, nonpolyglutamatable, quinazoline-based inhibitor of thymidylate synthaseA L Jackman, R Kimbell, G W Aherne, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Substituted-2-desamino-2-methyl-quinazolinones. A series of novel antitumour agentsF T Boyle, Z S Matusiak, L R Hughes, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Gamma-linked dipeptide analogues of 2-desamino-2-methyl-N10-propargyl-5,8- dideazafolate as antitumour agentsA L Jackman, G M Bisset, D I Jodrell, et al.
Pageof 4